Century Therapeutics, Inc.
IPSC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850119
In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Century Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- +2 vs. Q3 2021
- Shares held
- 21.1M
- +1.91M (+9.9%) vs. Q3 2021
- Total value
- $335.2M
- −$146.6M (−30.4%) vs. Q3 2021
- New holders
- 10
- 22 more added
- Sold out
- 8
- 7 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IPSC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 100 | $387.0M |
| Q1 2026 | 72 | $315.6M |
| Q4 2025 | 47 | $25.6M |
| Q3 2025 | 57 | $10.1M |
| Q2 2025 | 65 | $12.6M |
| Q1 2025 | 70 | $14.1M |
| Q4 2024 | 72 | $36.8M |
| Q3 2024 | 67 | $67.8M |
| Q2 2024 | 61 | $102.3M |
| Q1 2024 | 67 | $96.6M |
| Q4 2023 | 63 | $58.7M |
| Q3 2023 | 55 | $36.1M |
| Q2 2023 | 64 | $61.0M |
| Q1 2023 | 64 | $69.5M |
| Q4 2022 | 65 | $107.2M |
| Q3 2022 | 54 | $208.7M |
| Q2 2022 | 56 | $182.8M |
| Q1 2022 | 52 | $278.9M |
| Q4 2021 | 50 | $335.2M |
| Q3 2021 | 49 | $496.2M |
| Q2 2021 | 36 | $490.8M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Century Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 8,196,203 | $130.0M | 0.01% | +35,619+0.4% | Added |
| Casdin Capital, LLC | 3,206,380 | $50.9M | 1.43% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 1,164,094 | $18.5M | 0.03% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 914,094 | $14.5M | 0.26% | 00.0% | Unchanged |
| Avidity Partners Management LP | 851,522 | $13.5M | 0.29% | +112,253+15.2% | Added |
| BlackRock Inc. | 827,423 | $13.1M | 0.00% | +178,767+27.6% | Added |
| Octagon Capital Advisors LP | 702,623 | $11.1M | 2.17% | +100,000+16.6% | Added |
| Marshall Wace, LLP | 701,338 | $11.1M | 0.02% | +589,786+528.7% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 614,095 | $9.74M | 0.15% | 00.0% | Unchanged |
| Logos Global Management LP | 614,095 | $9.74M | 1.00% | −25,000−3.9% | Reduced |
| Vanguard Group Inc | 548,002 | $8.69M | 0.00% | +113,392+26.1% | Added |
| Morgan Stanley | 446,416 | $7.08M | 0.00% | +114,547+34.5% | Added |
| Point72 Asset Management, L.P. | 410,800 | $6.51M | 0.03% | +410,800 | New |
| OrbiMed Advisors LLC | 307,047 | $4.87M | 0.06% | −100,000−24.6% | Reduced |
| Deep Track Capital, LP | 250,000 | $3.96M | 0.29% | +250,000 | New |
| Geode Capital Management, LLC | 215,324 | $3.42M | 0.00% | +10,633+5.2% | Added |
| Woodline Partners LP | 208,082 | $3.30M | 0.05% | −42,012−16.8% | Reduced |
| State Street Corp | 188,148 | $2.98M | 0.00% | +39,386+26.5% | Added |
| JPMorgan Chase & Co | 140,953 | $2.23M | 0.00% | +77,529+122.2% | Added |
| Northern Trust Corp | 103,167 | $1.64M | 0.00% | −621−0.6% | Reduced |
| DAFNA Capital Management LLC | 100,135 | $1.59M | 0.40% | +20,135+25.2% | Added |
| Charles Schwab Investment Management Inc | 77,501 | $1.23M | 0.00% | +2,425+3.2% | Added |
| Walleye Capital LLC | 62,471 | $991.0K | 0.03% | +62,471 | New |
| Bank of America Corp | 41,126 | $652.0K | 0.00% | +13,343+48.0% | Added |
| Bank of New York Mellon Corp | 33,357 | $529.0K | 0.00% | +4,425+15.3% | Added |
| Parametrica Management Ltd | 28,855 | $459.0K | 0.46% | +100+0.3% | Added |
| Goldman Sachs Group Inc | 18,655 | $296.0K | 0.00% | +18,655 | New |
| Allspring Global Investments Holdings, LLC | 15,545 | $246.0K | 0.00% | +15,545 | New |
| D. E. Shaw & Co., Inc. | 15,037 | $238.0K | 0.00% | −5,819−27.9% | Reduced |
| Wells Fargo & Company | 14,851 | $235.0K | 0.00% | +14,793+25,505.2% | Added |
| HarbourVest Partners LLC | 14,631 | $232.0K | 0.03% | +14,631 | New |
| Nuveen Asset Management, LLC | 16,701 | $223.0K | 0.00% | 00.0% | Unchanged |
| Royce & Associates LP | 12,900 | $205.0K | 0.00% | +12,900 | New |
| Schonfeld Strategic Advisors LLC | 12,300 | $195.0K | 0.00% | −1,300−9.6% | Reduced |
| ProShare Advisors LLC | 10,273 | $163.0K | 0.00% | +10,273 | New |
| New York State Common Retirement Fund | 7,718 | $122.0K | 0.00% | +5,618+267.5% | Added |
| Deutsche Bank AG | 7,175 | $114.0K | 0.00% | +380+5.6% | Added |
| California State Teachers Retirement System | 6,381 | $101.0K | 0.00% | 00.0% | Unchanged |
| American International Group, Inc. | 6,276 | $100.0K | 0.00% | −187−2.9% | Reduced |
| UBS Group AG | 5,528 | $88.0K | 0.00% | +5,046+1,046.9% | Added |
| Citigroup Inc | 4,734 | $75.0K | 0.00% | +3,399+254.6% | Added |
| Hershey Trust Co | 4,723 | $75.0K | 0.00% | +4,723 | New |
| Tower Research Capital LLC (TRC) | 3,065 | $49.0K | 0.00% | +2,468+413.4% | Added |
| Royal Bank of Canada | 2,748 | $43.0K | 0.00% | +1,349+96.4% | Added |
| STRS Ohio | 2,700 | $42.0K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,105 | $17.0K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 905 | $14.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 200 | $3.00K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 159 | $3.00K | 0.00% | +159 | New |
| Patriot Financial Group Insurance Agency, LLC | 65 | $1.00K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −69,024−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −24,044−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −8,697−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −5,314−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −4,939−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −3,737−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |